Article
Pre-Clinical Blocking of PD-L1 molecule, which expression is down regulated by NF-κB…
medRxiv · 2018 · Christelle Vincent-Fabert
Key facts
| Title | Pre-Clinical Blocking of PD-L1 molecule, which expression is down regulated by NF-κB, JAK1/JAK2 and BTK inhibitors, induces regression of activated B-cell lymphoma. |
|---|---|
| First author | Christelle Vincent-Fabert |
| Journal | medRxiv |
| Published | Dec 21, 2018 |
| DOI | 10.1101/502922 |
| Product codes mentioned | JQP |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1